Page last updated: 2024-08-26

bismuth and Experimental Mammary Neoplasms

bismuth has been researched along with Experimental Mammary Neoplasms in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's5 (41.67)29.6817
2010's4 (33.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Deng, Y; Li, B; Li, Y; Liu, J; Miao, Y; Ouyang, R; Qin, X; Sun, Y; Xu, Y; Zhang, J1
Cui, C; Guo, Z; Jia, M; Liu, Y; Ma, K; Wang, D; Wang, L; Xu, P; Zheng, K; Zhou, H1
Chen, S; Fan, H; Sun, J; Wei, D; Zeng, L; Zhang, Y; Zhao, H; Zhu, Y1
Chen, C; Gu, Z; Hu, Z; Liu, J; Liu, Y; Tian, G; Wang, L; Yan, L; Yin, W; Zhao, Y; Zheng, X; Zhou, L1
Apostolidis, C; Esaias, C; Hobbs, RF; Huso, DL; Morgenstern, A; Sgouros, G; Song, H; Vajravelu, R1
Bruchertseifer, F; Lingappa, M; Morgenstern, A; Sgouros, G; Song, H; Thompson, S1
Akabani, G; Kennel, SJ; Zalutsky, MR1
Brechbiel, MW; Kelly, MP; Lee, FT; Scott, AM; Smyth, FE; Tahtis, K1
Kennel, SJ; Mirzadeh, S1
Branning, J; Davis, IA; Kabalka, GW; Kennel, SJ; Pan, H; Paulus, MJ1
Boll, RA; Davis, IA; Foote, LJ; Kennel, SJ; Lankford, TK; Mirzadeh, S1
Adam, C; Apostolidis, C; Becker, I; Becker, KF; Fischer, K; Huber, R; Kremmer, E; Miederer, M; Nikula, TK; Schuhmacher, C; Schwaiger, M; Seidl, C; Senekowitsch-Schmidtke, R1

Other Studies

12 other study(ies) available for bismuth and Experimental Mammary Neoplasms

ArticleYear
Ultrafast Synthesizing Bismuth Mesoporous Nanolitchi Radiosensitizer Loading High Dose DOX for CT-Guided Enhanced Chemoradiotherapy.
    ACS applied materials & interfaces, 2019, Nov-20, Volume: 11, Issue:46

    Topics: Animals; Bismuth; Cell Line, Tumor; Chemoradiotherapy; Doxorubicin; Drug Carriers; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanostructures; Porosity; Radiation-Sensitizing Agents; Tomography, X-Ray Computed

2019
CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells.
    Colloids and surfaces. B, Biointerfaces, 2019, Dec-01, Volume: 184

    Topics: A549 Cells; Animals; Antineoplastic Agents; Bismuth; CD47 Antigen; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Infrared Rays; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molecular Structure; Nanoparticles; Organoselenium Compounds; Particle Size; Phagocytosis; Photochemotherapy; Selenium Compounds; Surface Properties; Tumor Cells, Cultured

2019
A one-pot synthesis of multifunctional Bi
    Journal of materials chemistry. B, 2020, 05-14, Volume: 8, Issue:18

    Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Bismuth; Cell Line, Tumor; Cerium; Female; Infrared Rays; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanocomposites; Nanoparticles; NIH 3T3 Cells; Particle Size; Photosensitizing Agents; Phototherapy; Sulfides; Surface Properties

2020
Bismuth sulfide nanorods as a precision nanomedicine for in vivo multimodal imaging-guided photothermal therapy of tumor.
    ACS nano, 2015, Jan-27, Volume: 9, Issue:1

    Topics: Animals; Bismuth; Cell Line, Tumor; Male; Mammary Neoplasms, Experimental; Mice; Multimodal Imaging; Nanotubes; Photoacoustic Techniques; Phototherapy; Sulfides; Theranostic Nanomedicine; Tomography, X-Ray Computed

2015
Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.
    Cancer research, 2009, Dec-01, Volume: 69, Issue:23

    Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Female; Immunotoxins; Isotope Labeling; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Radioimmunotherapy; Radioisotopes; Rats; Receptor, ErbB-2; Tissue Distribution; Yttrium Radioisotopes

2009
Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer.
    Cancer research, 2010, Sep-01, Volume: 70, Issue:17

    Topics: Alpha Particles; Animals; Bismuth; Female; Immunoconjugates; Isothiocyanates; Liposomes; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasm Metastasis; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rats; Receptor, ErbB-2

2010
Microdosimetric analysis of alpha-particle-emitting targeted radiotherapeutics using histological images.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:5

    Topics: Alpha Particles; Animals; Astatine; Bismuth; Cell Survival; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Radioisotopes; Radiometry; Radiotherapy Dosage; Tumor Cells, Cultured

2003
Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Sep-15, Volume: 13, Issue:18 Pt 2

    Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; Bismuth; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Immunoglobulin Fab Fragments; Isothiocyanates; Lewis Blood Group Antigens; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Survival Rate; Tissue Distribution; Xenograft Model Antitumor Assays

2007
Vascular targeted radioimmunotherapy with 213Bi--an alpha-particle emitter.
    Nuclear medicine and biology, 1998, Volume: 25, Issue:3

    Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Radioimmunotherapy; Radioisotopes; Rats; Rats, Inbred F344; Tracheal Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured

1998
High resolution computed tomography and MRI for monitoring lung tumor growth in mice undergoing radioimmunotherapy: correlation with histology.
    Medical physics, 2000, Volume: 27, Issue:5

    Topics: Animals; Biophysical Phenomena; Biophysics; Bismuth; Female; Lung Neoplasms; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Radioisotopes; Tomography, X-Ray Computed

2000
Combination vascular targeted and tumor targeted radioimmunotherapy.
    Cancer biotherapy & radiopharmaceuticals, 1999, Volume: 14, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Bismuth; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Radiopharmaceuticals; Rats; Thrombomodulin; Tissue Distribution

1999
Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer.
    Cancer research, 2001, Apr-01, Volume: 61, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Bismuth; Cadherins; Female; Humans; Immunotoxins; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutation; Radioimmunotherapy; Radioisotopes; Stomach Neoplasms; Tissue Distribution; Transfection; Tumor Cells, Cultured

2001